Yu-Jet actively introduces innovative global therapies focusing on rare diseases and central nervous system (CNS) disorders.

Current products cover epilepsy, Fabry’s Disease, and cytomegalovirus (CMV) infection, across oral solutions, capsules, and injectable formulations.

Through strategic partnerships with global pharmaceutical companies, Yu-Jet expands patient access to clinically valuable and high-potential therapies in Taiwan.